Cytogen, Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was KRW 760.78 million compared to KRW 347.85 million a year ago. Net loss was KRW 18,771.23 million compared to KRW 10,870.61 million a year ago.

Basic loss per share from continuing operations was KRW 1,063 compared to KRW 642 a year ago. Diluted loss per share from continuing operations was KRW 1,063 compared to KRW 642 a year ago. Basic loss per share was KRW 1,063 compared to KRW 642 a year ago.